Target intelligence / Profile preview

Cutibacterium acnes 50S ribosomal subunit (50S subunit) (50S subunit)

Target
50S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The Cutibacterium acnes 50S ribosomal subunit is the larger component of the 70S ribosome in the Gram-positive bacterium formerly known as "Propionibacterium acnes" (Scholz & Kilian, 2016). This ribonucleoprotein complex is essential for bacterial protein synthesis, housing the peptidyl transferase center (PTC) where peptide bond formation occurs and the nascent peptide exit tunnel (NPET) (Wilson, 2014). It is a major therapeutic target in the treatment of acne vulgaris, as its inhibition halts the production of bacterial proteins necessary for growth and virulence. Several classes of antibiotics, including macrolides, lincosamides, and oxazolidinones, exert their antimicrobial effects by binding to specific sites within the 23S ribosomal RNA of this subunit (StatPearls, 2023). For instance, clindamycin and erythromycin bind near the PTC and NPET, respectively, to interfere with translation elongation (Walsh, 2003). However, the clinical utility of targeting this subunit is increasingly threatened by the development of resistance, often through point mutations in the 23S rRNA or enzymatic methylation by erm genes (PubMed, 2018). Consequently, this target remains a focal point for the development of novel dermatological anti-infectives designed to bypass common resistance mechanisms.

Other names
Propionibacterium acnes 50S ribosomal subunitC. acnes 50S ribosomeLarge ribosomal subunit50S ribosomal subunit
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, which prevents peptide bond formation at the peptidyl transferase center or blocks the exit of the nascent polypeptide chain through the ribosomal tunnel (Wilson, 2014; StatPearls, 2023).

03

Biological functions

Protein synthesisPeptidyl transferase activityTranslation
04

Disease associations

Acne vulgarisInfectionSkin infection
05

Safety considerations

Antibiotic resistanceSkin microbiome dysbiosisCross-resistance between macrolides and lincosamides
06

Interacting drugs

Clindamycin

6 more in the full profile.

07

Biomarkers

23S rRNA mutationserm gene expressionCFR gene

Beyond the preview

Go deeper on Cutibacterium acnes 50S ribosomal subunit (50S subunit) (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutibacterium acnes 50S ribosomal subunit (50S subunit) (50S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call